Dose selection is a key aspect of pediatric drug development. Getting the right dose for pediatric patients, especially newborns and infants, is critical but poses great scientific, practical, and ethical challenges. In addition, the significant differences in different growth and development stages also have an important impact on pediatric dose selection. On the one hand, adult data have reference significance for pediatric drug dose selection and are an important basis for pediatric drug research design and data analysis. On the other hand, model-informed drug development is widely used in dose exposure-response characterization and optimization of dose selection for pediatric drugs. This paper summarizes and analyzes the experience of pediatric drug dose selection, which will serve as a referance for Chinese pediatric drug developers and the follow-up government regulation and policy makers.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |